DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

197.48 -3.77 (-1.87%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $197.48 -1.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $200.46
Previous Close $201.25
Daily Range $197.15 - $201.95
52-Week Range $106.00 - $204.66
Market Cap $66.4B
P/E Ratio 75.37
Dividend (Yield) $0.00 (0.0%)
Volume 6,588,151
Average Daily Volume 3,179,182
Current FY EPS $2.96

Sector

Healthcare

Industry

Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

5 Stocks With Jaw-Dropping Growth Potential

These five small-cap growth stocks could soar in 2015. Here's why.

Valeant Pharmaceuticals To Acquire Salix

Valeant Pharmaceuticals to Acquire Salix

Morgan Stanley Reiterates Overweight, Raises Price Target On Valeant Pharmaceuticals On New Proforma

Morgan Stanley Reiterates Overweight, Raises Price Target On Valeant Pharmaceuticals On New Proforma Model For SLXP

Salix Pharmaceuticals Investors Should Now Walk Away With Their Heads Held High

Valeant Pharmaceuticals Earnings Analysis

Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target

A European Biotech Stock Basket For 2015

Valeant Pharmaceuticals International's (VRX) CEO Mike Pearson on Q4 2014 Results - Earnings Call Tr

Valeant Pharmaceuticals International's (VRX) CEO Mike Pearson on Q4 2014 Results - Earnings Call Transcript

Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity

See More VRX News...

VRX's Top Competitors

VRX $197.48 (-1.87%)
Current stock: VRX
JNJ $102.51 (-0.28%)
Current stock: JNJ
NVS $102.40 (-0.58%)
Current stock: NVS
RHHBY $34.13 (0.80%)
Current stock: RHHBY